Epithelial cell–derived cytokines: more than just signaling the alarm
F Roan, K Obata-Ninomiya… - The Journal of clinical …, 2019 - Am Soc Clin Investig
The epithelial cell–derived cytokines thymic stromal lymphopoietin (TSLP), IL-33, and IL-25
are central regulators of type 2 immunity, which drives a broad array of allergic responses …
are central regulators of type 2 immunity, which drives a broad array of allergic responses …
[HTML][HTML] Inflammation and immunity in IPF pathogenesis and treatment
P Heukels, CC Moor, JH Von der Thüsen… - Respiratory …, 2019 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a progressive, and ultimately fatal, chronic interstitial
lung disease characterized by enhanced extracellular matrix deposition. Repetitive alveolar …
lung disease characterized by enhanced extracellular matrix deposition. Repetitive alveolar …
[HTML][HTML] The central role of IL-33/IL-1RL1 pathway in asthma: from pathogenesis to intervention
AKS Jayalatha, L Hesse, ME Ketelaar… - Pharmacology & …, 2021 - Elsevier
Abstract Interleukin-33 (IL-33), a member of the IL-1 family, and its cognate receptor,
Interleukin-1 receptor like-1 (IL-1RL1 or ST2), are susceptibility genes for childhood asthma …
Interleukin-1 receptor like-1 (IL-1RL1 or ST2), are susceptibility genes for childhood asthma …
The IL-1 cytokine family and its role in inflammation and fibrosis in the lung
LA Borthwick - Seminars in immunopathology, 2016 - Springer
The IL-1 cytokine family comprises 11 members (7 ligands with agonist activity, 3 receptor
antagonists and 1 anti-inflammatory cytokine) and is recognised as a key mediator of …
antagonists and 1 anti-inflammatory cytokine) and is recognised as a key mediator of …
IL‐33: biological properties, functions, and roles in airway disease
LY Drake, H Kita - Immunological reviews, 2017 - Wiley Online Library
Summary Interleukin (IL)‐33 is a key cytokine involved in type 2 immunity and allergic
airway diseases. Abundantly expressed in lung epithelial cells, IL‐33 plays critical roles in …
airway diseases. Abundantly expressed in lung epithelial cells, IL‐33 plays critical roles in …
IL-33 is more potent than IL-25 in provoking IL-13–producing nuocytes (type 2 innate lymphoid cells) and airway contraction
JL Barlow, S Peel, J Fox, V Panova… - Journal of allergy and …, 2013 - Elsevier
Background IL-25 and IL-33 belong to distinct cytokine families, but experimental mouse
studies suggest their immunologic functions in type 2 immunity are almost entirely …
studies suggest their immunologic functions in type 2 immunity are almost entirely …
Role of IL-33 in inflammation and disease
AM Miller - Journal of inflammation, 2011 - Springer
Abstract Interleukin (IL)-33 is a new member of the IL-1 superfamily of cytokines that is
expressed by mainly stromal cells, such as epithelial and endothelial cells, and its …
expressed by mainly stromal cells, such as epithelial and endothelial cells, and its …
Pathophysiology of allergic inflammation
PJ Barnes - Immunological reviews, 2011 - Wiley Online Library
Allergic inflammation is due to a complex interplay between several inflammatory cells,
including mast cells, basophils, lymphocytes, dendritic cells, eosinophils, and sometimes …
including mast cells, basophils, lymphocytes, dendritic cells, eosinophils, and sometimes …
Long-term IL-33–producing epithelial progenitor cells in chronic obstructive lung disease
Chronic obstructive lung disease is characterized by persistent abnormalities in epithelial
and immune cell function that are driven, at least in part, by infection. Analysis of …
and immune cell function that are driven, at least in part, by infection. Analysis of …
Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33
CA Christianson, NP Goplen, I Zafar, C Irvin… - Journal of Allergy and …, 2015 - Elsevier
Background Asthma in a mouse model spontaneously resolves after cessation of allergen
exposure. We developed a mouse model in which asthma features persisted for 6 months …
exposure. We developed a mouse model in which asthma features persisted for 6 months …